Jinwon Life Sciences, Top Search Ranking... Stock Price -1.94%
Jinwon Life Sciences is trading at 10,100 KRW as of 9:30 AM on the 26th, down 1.94% from the previous day. This represents a 27.34% decrease compared to April 23. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.
Over the past five days, individual investors have net sold 42,082 shares, while foreigners and institutions have net bought 22,155 shares and 684 shares, respectively.
On May 21, Jinwon Life Sciences became a market topic with the news "US Inovio COVID-19 vaccine increases antibody formation in mice."
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "I Will Give Them a Chance for Self-Examination": Chinese Scientific Community Shaken by Influencer's Preemptive Whistleblowing
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
